Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$1.29 - $2.22 $107,311 - $184,675
83,187 New
83,187 $112,000
Q2 2023

Jul 18, 2023

BUY
$2.07 - $2.92 $26,723 - $37,697
12,910 Added 5.59%
243,917 $524,000
Q1 2023

Apr 13, 2023

BUY
$2.81 - $6.71 $12,383 - $29,570
4,407 Added 1.94%
231,007 $672,000
Q4 2022

Jan 23, 2023

BUY
$2.74 - $6.87 $3,619 - $9,075
1,321 Added 0.59%
226,600 $0
Q3 2022

Oct 26, 2022

SELL
$2.35 - $4.66 $4,150 - $8,229
-1,766 Reduced 0.78%
225,279 $716,000
Q2 2022

Jul 25, 2022

SELL
$2.09 - $3.71 $21,896 - $38,869
-10,477 Reduced 4.41%
227,045 $728,000
Q1 2022

May 02, 2022

BUY
$2.84 - $4.52 $177,647 - $282,735
62,552 Added 35.75%
237,522 $719,000
Q4 2021

Jan 28, 2022

BUY
$3.87 - $6.59 $677,133 - $1.15 Million
174,970 New
174,970 $780,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $37.6M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.